RCUS

NYSE Arcus Biosciences, Inc.
Sep 30, 2026 · 5:56 AM ET LAST TRADE Market Closed

$25.56 ↓ -0.09 (-0.35%) Trading Down from the previous close of $25.65

YTD change
+7.26%
vs 20-day SMA
-3.79%
vs 200-day SMA
+3.32%

Price ranges

Previous day
$24.76 $26.04
open $24.93 close $25.65
+$0.72 (+2.89%)
Today
$0.00 $0.00
$25.56
Past week
$24.34 $27.90
from $26.87 now $25.56
-$1.31 (-4.88%)
Past month
$23.31 $31.47
from $29.28 now $25.56
-$3.72 (-12.70%)
This year
$18.52 $31.74
from $23.83 now $25.56
+$1.73 (+7.26%)

Price & Performance

+5.00 (+24.21%) / 6M

$19.78$24.00$28.22$32.44Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 47.9% away from all-time highs of $49.10
  • RCUS is up 7% since the beginning of the year
  • RCUS is up 88% over the past 12 months
  • RCUS is down 13% over the past 1 month
  • 16% of all RCUS investors are betting against RCUS
  • Number of investors short RCUS has gone up 5% versus last month

RCUS reads neutral: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +88.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.72
Earnings momentum +19.2% Quarterly EPS growth
Quarterly change +19.2%

Valuation

P/E ratio N/A
Enterprise value $2.6B
Beta 1.51

Balance sheet & scale

IncomeN/A
Revenue$117.0M
Cash$702.0M
Debt$114.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.3B

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.